Cenci, Tonia
Cenci, Tonia
ROMA - Istituto di ematologia
Clinical and NGS predictors of response to regorafenib in recurrent glioblastoma
2022 Chiesa, S.; Mangraviti, A.; Martini, M.; Cenci, T.; Mazzarella, C.; Gaudino, S.; Bracci, S.; Martino, A.; Della Pepa, G. M.; Offi, M.; Gessi, M.; Russo, R.; Martucci, M.; Beghella Bartoli, F.; Larocca, L. M.; Lauretti, L.; Olivi, A.; Pallini, R.; Balducci, M.; D'Alessandris, Q. G.
Dissecting Stemness in Aggressive Intracranial Meningiomas: Prognostic Role of SOX2 Expression
2022 Di Bonaventura, R.; Martini, M.; Cenci, T.; Caccavella, V. M.; Barresi, V.; Gessi, M.; Albanese, A.; Lauretti, L.; Pallini, R.; D'Alessandris, Q. G.; Olivi, A.
The bladder epicheck test and cytology in the follow-up of patients with non-muscle-invasive high grade bladder carcinoma
2022 Pierconti, F.; Martini, M.; Cenci, T.; Fiorentino, V.; Gianfrancesco, L. D.; Ragonese, M.; Bientinesi, R.; Rossi, E.; Larocca, L. M.; Racioppi, M.; Bassi, P. F.
Discordance of KRAS Mutational Status between Primary Tumors and Liver Metastases in Colorectal Cancer: Impact on Long-Term Survival Following Radical Resection
2021 Ardito, Francesco; Razionale, Francesco; Salvatore, Lisa; Cenci, Tonia; Vellone, Maria; Basso, Michele; Panettieri, Elena; Calegari, Maria Alessandra; Tortora, Giampaolo; Martini, Maurizio; Giuliante, Felice
how limited molecular testing can also offer diagnostic and prognostic evaluation of thyroid nodules processed with liquid based cytology. Role of TERT promoter and BRAF V600E mutation analysis
2021 Dell'aquila, M; Fiorentino, V; Martini, M; Capodimonti, S; Cenci, T; Lombardi, Cp; Raffaelli, M; Pontecorvi, A; Fadda, G; Pantanowitz, L; Larocca, Lm; Rossi, E.
Methylation study of the Paris system for reporting urinary (TPS) categories
2021 Pierconti, F.; Martini, M.; Cenci, T.; Fiorentino, V.; Sacco, E.; Bientinesi, R.; Pugliese, D.; Iacovelli, R.; Schinzari, G.; Larocca, L. M.; Bassi, P. F.
The combination cytology/epichek test in non muscle invasive bladder carcinoma follow-up: Effective tool or useless expence?
2021 Pierconti, F.; Martini, M.; Fiorentino, V.; Cenci, T.; Capodimonti, S.; Straccia, P.; Sacco, E.; Pugliese, D.; Cindolo, L.; Larocca, L. M.; Bassi, P. F.
C-myc expression is a possible keystone in the colorectal cancer resistance to egfr inhibitors
2020 Strippoli, A.; Cocomazzi, A.; Basso, M.; Cenci, T.; Ricci, R.; Pierconti, F.; Cassano, A.; Fiorentino, V.; Barone, C.; Bria, E.; Ricci-Vitiani, L.; Tortora, G.; Larocca, L. M.; Martini, M.
c-MYC Expression Is a Possible Keystone in the Colorectal Cancer Resistance to EGFR Inhibitors.
2020 Strippoli, A; Cocomazzi, S; Basso, M; Cenci, T; Ricci, Riccardo; Pierconti, F; Cassano, A; Fiorentino, V; Barone, C; Bria, E; Ricci-Vitiani, L; Tortora, G; Larocca, Lm; Martini, M.
Tailored therapy for recurrent glioblastoma. Report of a personalized molecular approach
2020 D'Alessandris, Quintino G; Martini, Maurizio; Cenci, Tonia; Di Bonaventura, Rina; Lauretti, Liverana; Stumpo, Vittorio; Olivi, Alessandro; Larocca, Luigi M; Pallini, Roberto; Montano, Nicola
Preferential MGMT methylation could predispose a subset of KIT/PDGFRA-WT GISTs, including SDH-deficient ones, to respond to alkylating agents
2019 Ricci, Riccardo; Martini, Maurizio; Ravegnini, Gloria; Cenci, Tonia; Milione, Massimo; Lanza, Paola; Pierconti, Francesco; Santini, Donatella; Angelini, Sabrina; Biondi, Alberto; Rosa, Fausto; Alfieri, Sergio; Clemente, Gennaro; Persiani, Roberto; Cassano, Alessandra; Pantaleo, Maria A.; Larocca, Luigi Maria
Preferential MGMT methylation could predispose a subset of KIT/PDGFRA-WT GISTs, including SDH-deficient ones, to respond to alkylating agents
2019 Ricci, Riccardo; Martini, Maurizio; Ravegnini, Gloria; Cenci, Tonia; Milione, Massimo; Lanza, Paola; Pierconti, Francesco; Santini, Donatella; Angelini, Sabrina; Biondi, Alberto; Rosa, Fausto; Alfieri, Sergio; Clemente, Gennaro; Persiani, Roberto; Cassano, Alessandra; Pantaleo, Maria A.; Larocca, Luigi M.
Protein Expression of PTTG-1, OCT-4, and KLF-4 in Seminoma: A Pilot Study.
2019 Grande, G; Milardi, D; Martini, M; Cenci, T; Gulino, G; Mancini, F; Bianchi, A; Pontecorvi, A; Pierconti, F.
Eight-year survival of a recurrent glioblastoma patient treated with molecularly tailored therapy: a case report
2018 D'Alessandris, Qg; Montano, N; Martini, M; Cenci, T; Lauretti, L; Stumpo, V; Pignotti, Fabrizio; Olivi, A; Fernandez, Marquez; E, ; Larocca, Lm; Pallini, R
Morphology combined with ancillary techniques: An algorithm approach for thyroid nodules
2018 Rossi, E.; Martini, M.; Capodimonti, S.; Cenci, T.; Bilotta, M.; Pierconti, F.; Pontecorvi, A.; Lombardi, C. P.; Fadda, G.; Larocca, L. M.
Morphology combined with ancillary techniques: An algorithm approach for thyroid nodules
2018 Rossi, Esther Diana; Martini, Maurizio; Capodimonti, Sara; Cenci, Tonia; Bilotta, Mirna; Pierconti, Francesco; Pontecorvi, Alfredo; Lombardi, Celestino Pio; Fadda, Guido; Larocca, Luigi Maria
Plexiform architecture in gastrointestinal stromal tumors is not restricted to succinate dehydrogenase-deficient cases
2018 Giustiniani, Maria Cristina; Papa, Valerio; Martini, Maurizio; Castri, Federica; Cenci, Tonia; Alfieri, Sergio; Ricci, Riccardo
The Immunohistochemical Analysis of SOCS3 Protein Identifies a Subgroup of Prostatic Cancer Biopsies with Aggressive Behavior
2018 Pierconti, Francesco; Martini, Maurizio; Cenci, Tonia; Larocca, Luigi M.
To obtain more with less cytologic samples with ancillary molecular techniques-the useful role of liquid-based cytology
2018 Martini, Maurizio; Capodimonti, Sara; Cenci, Tonia; Bilotta, Mirna; Fadda, Guido; Larocca, Luigi Maria; Rossi, Esther Diana
A phase 2 study of temozolomide in pretreated metastatic colorectal cancer with MGMT promoter methylation
2017 Calegari, M. A.; Inno, A.; Monterisi, S.; Orlandi, A.; Santini, D.; Basso, M.; Cassano, A.; Martini, M.; Cenci, T.; De Pascalis, I.; Camarda, F.; Barbaro, B.; Larocca, L. M.; Gori, S.; Tonini, G.; Barone, C.
| Data di pubblicazione | Titolo | Autore(i) | File |
|---|---|---|---|
| 1-gen-2022 | Clinical and NGS predictors of response to regorafenib in recurrent glioblastoma | Chiesa, S.; Mangraviti, A.; Martini, M.; Cenci, T.; Mazzarella, C.; Gaudino, S.; Bracci, S.; Martino, A.; Della Pepa, G. M.; Offi, M.; Gessi, M.; Russo, R.; Martucci, M.; Beghella Bartoli, F.; Larocca, L. M.; Lauretti, L.; Olivi, A.; Pallini, R.; Balducci, M.; D'Alessandris, Q. G. | |
| 1-gen-2022 | Dissecting Stemness in Aggressive Intracranial Meningiomas: Prognostic Role of SOX2 Expression | Di Bonaventura, R.; Martini, M.; Cenci, T.; Caccavella, V. M.; Barresi, V.; Gessi, M.; Albanese, A.; Lauretti, L.; Pallini, R.; D'Alessandris, Q. G.; Olivi, A. | |
| 1-gen-2022 | The bladder epicheck test and cytology in the follow-up of patients with non-muscle-invasive high grade bladder carcinoma | Pierconti, F.; Martini, M.; Cenci, T.; Fiorentino, V.; Gianfrancesco, L. D.; Ragonese, M.; Bientinesi, R.; Rossi, E.; Larocca, L. M.; Racioppi, M.; Bassi, P. F. | |
| 1-gen-2021 | Discordance of KRAS Mutational Status between Primary Tumors and Liver Metastases in Colorectal Cancer: Impact on Long-Term Survival Following Radical Resection | Ardito, Francesco; Razionale, Francesco; Salvatore, Lisa; Cenci, Tonia; Vellone, Maria; Basso, Michele; Panettieri, Elena; Calegari, Maria Alessandra; Tortora, Giampaolo; Martini, Maurizio; Giuliante, Felice | |
| 1-gen-2021 | how limited molecular testing can also offer diagnostic and prognostic evaluation of thyroid nodules processed with liquid based cytology. Role of TERT promoter and BRAF V600E mutation analysis | Dell'aquila, M; Fiorentino, V; Martini, M; Capodimonti, S; Cenci, T; Lombardi, Cp; Raffaelli, M; Pontecorvi, A; Fadda, G; Pantanowitz, L; Larocca, Lm; Rossi, E. | |
| 1-gen-2021 | Methylation study of the Paris system for reporting urinary (TPS) categories | Pierconti, F.; Martini, M.; Cenci, T.; Fiorentino, V.; Sacco, E.; Bientinesi, R.; Pugliese, D.; Iacovelli, R.; Schinzari, G.; Larocca, L. M.; Bassi, P. F. | |
| 1-gen-2021 | The combination cytology/epichek test in non muscle invasive bladder carcinoma follow-up: Effective tool or useless expence? | Pierconti, F.; Martini, M.; Fiorentino, V.; Cenci, T.; Capodimonti, S.; Straccia, P.; Sacco, E.; Pugliese, D.; Cindolo, L.; Larocca, L. M.; Bassi, P. F. | |
| 1-gen-2020 | C-myc expression is a possible keystone in the colorectal cancer resistance to egfr inhibitors | Strippoli, A.; Cocomazzi, A.; Basso, M.; Cenci, T.; Ricci, R.; Pierconti, F.; Cassano, A.; Fiorentino, V.; Barone, C.; Bria, E.; Ricci-Vitiani, L.; Tortora, G.; Larocca, L. M.; Martini, M. | |
| 1-gen-2020 | c-MYC Expression Is a Possible Keystone in the Colorectal Cancer Resistance to EGFR Inhibitors. | Strippoli, A; Cocomazzi, S; Basso, M; Cenci, T; Ricci, Riccardo; Pierconti, F; Cassano, A; Fiorentino, V; Barone, C; Bria, E; Ricci-Vitiani, L; Tortora, G; Larocca, Lm; Martini, M. | |
| 1-gen-2020 | Tailored therapy for recurrent glioblastoma. Report of a personalized molecular approach | D'Alessandris, Quintino G; Martini, Maurizio; Cenci, Tonia; Di Bonaventura, Rina; Lauretti, Liverana; Stumpo, Vittorio; Olivi, Alessandro; Larocca, Luigi M; Pallini, Roberto; Montano, Nicola | |
| 1-gen-2019 | Preferential MGMT methylation could predispose a subset of KIT/PDGFRA-WT GISTs, including SDH-deficient ones, to respond to alkylating agents | Ricci, Riccardo; Martini, Maurizio; Ravegnini, Gloria; Cenci, Tonia; Milione, Massimo; Lanza, Paola; Pierconti, Francesco; Santini, Donatella; Angelini, Sabrina; Biondi, Alberto; Rosa, Fausto; Alfieri, Sergio; Clemente, Gennaro; Persiani, Roberto; Cassano, Alessandra; Pantaleo, Maria A.; Larocca, Luigi Maria | |
| 1-gen-2019 | Preferential MGMT methylation could predispose a subset of KIT/PDGFRA-WT GISTs, including SDH-deficient ones, to respond to alkylating agents | Ricci, Riccardo; Martini, Maurizio; Ravegnini, Gloria; Cenci, Tonia; Milione, Massimo; Lanza, Paola; Pierconti, Francesco; Santini, Donatella; Angelini, Sabrina; Biondi, Alberto; Rosa, Fausto; Alfieri, Sergio; Clemente, Gennaro; Persiani, Roberto; Cassano, Alessandra; Pantaleo, Maria A.; Larocca, Luigi M. | |
| 1-gen-2019 | Protein Expression of PTTG-1, OCT-4, and KLF-4 in Seminoma: A Pilot Study. | Grande, G; Milardi, D; Martini, M; Cenci, T; Gulino, G; Mancini, F; Bianchi, A; Pontecorvi, A; Pierconti, F. | |
| 1-gen-2018 | Eight-year survival of a recurrent glioblastoma patient treated with molecularly tailored therapy: a case report | D'Alessandris, Qg; Montano, N; Martini, M; Cenci, T; Lauretti, L; Stumpo, V; Pignotti, Fabrizio; Olivi, A; Fernandez, Marquez; E, ; Larocca, Lm; Pallini, R | |
| 1-gen-2018 | Morphology combined with ancillary techniques: An algorithm approach for thyroid nodules | Rossi, E.; Martini, M.; Capodimonti, S.; Cenci, T.; Bilotta, M.; Pierconti, F.; Pontecorvi, A.; Lombardi, C. P.; Fadda, G.; Larocca, L. M. | |
| 1-gen-2018 | Morphology combined with ancillary techniques: An algorithm approach for thyroid nodules | Rossi, Esther Diana; Martini, Maurizio; Capodimonti, Sara; Cenci, Tonia; Bilotta, Mirna; Pierconti, Francesco; Pontecorvi, Alfredo; Lombardi, Celestino Pio; Fadda, Guido; Larocca, Luigi Maria | |
| 1-gen-2018 | Plexiform architecture in gastrointestinal stromal tumors is not restricted to succinate dehydrogenase-deficient cases | Giustiniani, Maria Cristina; Papa, Valerio; Martini, Maurizio; Castri, Federica; Cenci, Tonia; Alfieri, Sergio; Ricci, Riccardo | |
| 1-gen-2018 | The Immunohistochemical Analysis of SOCS3 Protein Identifies a Subgroup of Prostatic Cancer Biopsies with Aggressive Behavior | Pierconti, Francesco; Martini, Maurizio; Cenci, Tonia; Larocca, Luigi M. | |
| 1-gen-2018 | To obtain more with less cytologic samples with ancillary molecular techniques-the useful role of liquid-based cytology | Martini, Maurizio; Capodimonti, Sara; Cenci, Tonia; Bilotta, Mirna; Fadda, Guido; Larocca, Luigi Maria; Rossi, Esther Diana | |
| 1-gen-2017 | A phase 2 study of temozolomide in pretreated metastatic colorectal cancer with MGMT promoter methylation | Calegari, M. A.; Inno, A.; Monterisi, S.; Orlandi, A.; Santini, D.; Basso, M.; Cassano, A.; Martini, M.; Cenci, T.; De Pascalis, I.; Camarda, F.; Barbaro, B.; Larocca, L. M.; Gori, S.; Tonini, G.; Barone, C. |